Epilepsy trials in Russia

2 of 3 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders.

  Where

  Moscow

  Age

  1 year to 14 years

  People

  5

  Run by

  Pirogov Russian National Research Medical University

  See details and how to joinNCT07363603
• No phaseTaking people
  StereoEEG Motor Neuronal Potentials Decoding

  Where

  Moscow

  Age

  18 years to 70 years

  People

  30

  Run by

  Research Center of Neurology, Russia

  See details and how to joinNCT06432907